Viewing nowCombinationPimaten Tablet 60/5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Aju Pharmaceutical Co., Ltd.

MFDS item code 202300105 · Approved 2023.01.06 · Insurance code 654006040
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
This medication helps lower blood pressure more effectively in patients with essential hypertension who struggle to control blood pressure even with Pimansartan Potassium monotherapy. Essential hypertension is high blood pressure that occurs without a specific cause, making blood pressure management crucial. This medication dilates blood vessels, lowering blood pressure and reducing the strain on the heart. It can be used in conjunction with other treatments when monotherapy is not effective. This contributes to stable blood pressure control in patients. Ultimately, it is used for the treatment of essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended to adjust the dose of fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Older adults No initial dose adjustment is required for older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication’s active ingredient or similar components, those who are pregnant or breastfeeding, patients on kidney dialysis, those with severely compromised liver function, bile duct obstruction, certain kidney diseases, or diabetic nephropathy should not take this medication. Patients with low blood volume or sodium, impaired kidney function, renal artery hypertension, heart valve disease, severe hypotension, elderly individuals, and those with hypersensitivity to specific pigments should take special caution when using this medication and should be closely monitored. This medication can commonly cause side effects such as dizziness, headaches, facial or limb swelling, urination issues, insomnia, and flushing, while severe side effects such as major renal problems or hypotension may occur rarely. Since this medication lowers blood pressure, patients experiencing symptoms of hypotension should consult a doctor immediately, and in severe cases, seek appropriate treatment at a hospital. This medication can interact with other drugs; therefore, it is essential to inform the doctor if taking potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, specific antibiotics, and other antihypertensive medications. Taking this medication during pregnancy poses a serious risk to the fetus; thus, women planning a pregnancy or who are pregnant should consult with their doctor before taking it, and it is not recommended during breastfeeding. For children under 18 years old, safety and efficacy have not been established, so it is best not to use it. Generally, elderly patients do not require dose adjustments; however, some elderly individuals may be more sensitive to the medication and should be closely monitored. Patients with moderate to severe liver impairment should not take this medication. In cases of overdose, severe hypotension or cardiac irregularities may occur, requiring immediate medical attention for appropriate treatment. This medication should be kept out of reach of children and should not be transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and must be stored in a light-blocking container. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain efficacy.
Orange, round-edged, square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Aju Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.